Articles Tagged With: COVID-19
-
Can New Antivirals Against COVID-19 Solve Staff Shortages?
One answer to the healthcare staffing shortages could be a newly developed antiviral that works against SARS-CoV-2 much like influenza antivirals negate the symptoms of flu. -
Supreme Court Upholds Healthcare Vaccine Mandate
Hospitals still struggling to vaccinate all workers received good news on Jan. 13, when the U.S. Supreme Court ruled the federal government can enforce its COVID-19 vaccine mandate for healthcare workers. Justices threw out two lawsuits representing more than 20 states, ruling that mandating COVID-19 vaccination of healthcare workers is within the limits of federal law. -
An Epidemic of Long COVID May Be the Legacy of Omicron
The loosening of COVID-19 policies and shortening duration of precautions signal the emergence of what some call the “inevitability camp”: those who believe everyone will contract the rapidly spreading omicron variant, thereby generating herd immunity. There is one major problem with this view. It is becoming increasingly apparent that 14% (estimated range 2%-30%) of those infected with omicron will develop long COVID, a prolonged set of neurological and physical maladies that have haunted some people since the pandemic began in 2020. -
Pandemic Presenteeism: CA Says HCWs with COVID-19 Can Skip Isolation
A California public health policy allowing asymptomatic healthcare workers with COVID-19 to remain on duty sparked outrage among some nurses, who say it threatens their prime mission to protect and care for patients. -
Acute Trauma Care in the Era of SARS-CoV-2
COVID-19 has affected every aspect of medical care. The authors discuss modifications of trauma care to protect both patients and providers.
-
FDA Modifies Authorizations for COVID-19 Therapeutics
In the face of the omicron onslaught, certain once-reliable monoclonal antibodies are not as effective.
-
Sotrovimab Injection
In vitro neutralization data, artificial intelligence modeling, and anecdotal reports suggest sotrovimab is effective against the omicron variant while the efficacy of other monoclonal antibodies appears to wane.
-
SARS-CoV-2 as a North American Zoonosis
COVID-19 has become a North American zoonosis endemic in the Northeastern white-tailed deer population. Whether it causes symptomatic infection is unclear, but most infections likely are subclinical, with viral shedding in nasal secretions and feces. Now that infection has become established in this animal group, it likely will spread easily.
-
Effect of COVID-19 on Patient Severity of Illness, Evaluating Hospital Performance
Patients with COVID-19 not only experience a higher mortality rate, but also a longer length of stay than other viral illness patients, even when adjusted for other patient factors such as age and comorbidities. Because of this, it is a challenge to evaluate hospital performance during the pandemic. -
In Addition to Vaccination, Can More Be Done to Prevent Severe COVID-19?
Using data for more than 1.2 million Americans who completed primary vaccination against COVID-19, severe disease outcomes were rare; however, vaccinated persons aged ≥ 65 years with immunosuppression or other underlying conditions were found to be at higher risk.